Guilherme Cantuaria

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)”.

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)

Gynecologic Oncology Reports(2020)10.1016/j.gore.2019.100532

N/A

0DataRank · unranked

17 citations

Virginia L. Filiaci, Stefania Bellone, Roisin E. O’Cearbhaill, Elena Ratner, Cara Mathews +7 more

490 DiRECT Cohort: An NCORP longitudinal observational trial for disparities in results of immune checkpoint inhibitor treatment between Black and White cancer patients

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0490

N/A

0DataRank · unranked

0 citations

Christine B. Ambrosone, Lori C. Sakoda, Igor PuzanovCI, Eva Culakova, Michelle C. Janelsins +13 more

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.094

N/A

0DataRank · unranked

0 citations

Danielle Enserro, Heather A. Lankes, Kyle C. Strickland, Rebecca A. Previs, Matthew Powell +19 more